CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 167 enrolled
Drug / intervention
Proton Radiation +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00831623
NCT00831623N/ACompleted
CompareCT.gov

Phase I-II Trial of Hypofractionated Conformal Proton Beam Radiation Therapy for Favorable-risk Prostate Cancer

Loma Linda University·interventional·Posted Jan 29, 2009·Updated Mar 13, 2023

In Brief

A clinical study evaluating Proton Radiation and Proton for Prostate Cancer. Completed, enrolled 167 participants across 1 site.

Detailed Summary

The purpose of this study is to determine hypofractionated conformal proton beam radiation therapy of prostate cancer can achieve similar treatment benefits as our current institutional standard with conventional fractionation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJan 29, 2009
Enrollment StartFeb 17, 2009
Primary CompletionJul 18, 2019
TodayJul 2, 2026
Enrollment to primary: 10.4 yearsPosted 17.4 years ago

Interventions

Proton Radiationradiation

3 Cobalt Gray Equivalent (CGE) /Day to isocenter, one treatment per day, 5 days per week for 20 treatments (=60 CGE to isocenter/20 fractions)

Protonradiation

As above